The risk for readmission in schizophrenia patients treated with long-acting injectable (typical or atypical) versus oral antipsychotics

被引：0
|
作者：
Onn, R. [1 ]
Krivoy, A. [1 ,2 ]
Weizman, A. [1 ,2 ]
Hochman, E. [1 ,2 ]
Valevski, A. [1 ,2 ]
机构：
[1] Geha Mental Hlth Ctr, Psychiat, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30676-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.027
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 50 条
  • [21] Long-Acting Typical and Atypical Antipsychotics in Treatment of Schizophrenia: A Retrospective Comparison
    Virit, Osman
    Altindag, Abdurrahman
    Bulbul, Feridun
    Savas, Haluk Asuman
    Dalkilic, Alican
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (02): : 119 - 127
  • [22] Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia
    Lafeuille, Marie-Helene
    Dean, Jason
    Carter, Valerie
    Duh, Mei Sheng
    Fastenau, John
    Dirani, Riad
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1643 - 1655
  • [23] Long-Acting Injectable Antipsychotics and Infections in Schizophrenia
    Malham, Kali M.
    Miller, Brian J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (03) : 259 - 262
  • [24] The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
    Miyamoto S.
    Wolfgang Fleischhacker W.
    Current Treatment Options in Psychiatry, 2017, 4 (2) : 117 - 126
  • [25] LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA
    Fleischhacker, W. W.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [26] Two Long-Acting Injectable Antipsychotics for Schizophrenia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1481): : 152 - 153
  • [27] MEDICATION ADHERENCE AND DISCONTINUATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ARIPIPRAZOLE ONCE-MONTHLY LONG-ACTING INJECTABLE VERSUS THOSE TREATED WITH ORAL ANTIPSYCHOTICS
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Pulasky, Beth
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S248 - S249
  • [28] COMPARING COMPLIANCE BY RACE AND ETHNICITY FOR SCHIZOPHRENIA PATIENTS ON ORAL OR LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    McLean, J.
    Wei, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S326 - S326
  • [29] Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review
    Canas, Fernando
    Moeller, Hans-Juergen
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (05) : 683 - 697
  • [30] Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2013, 39 : S121 - S123
12345